4.6 Article

Prognostic Value of the Neutrophil-to-Lymphocyte Ratio before and after Radiotherapy for Anaplastic Thyroid Carcinoma

Related references

Note: Only part of the references are listed.
Article Endocrinology & Metabolism

Real-World Experience with Targeted Therapy for the Treatment of Anaplastic Thyroid Carcinoma

Priyanka C. Iyer et al.

THYROID (2018)

Review Biotechnology & Applied Microbiology

Prognostic utility of baseline neutrophil-to-lymphocyte ratio in patients receiving immune checkpoint inhibitors: a review and meta-analysis

Danielle Benedict Sacdalan et al.

ONCOTARGETS AND THERAPY (2018)

Review Biochemistry & Molecular Biology

Therapeutic advances in anaplastic thyroid cancer: a current perspective

Shikha Saini et al.

MOLECULAR CANCER (2018)

Article Oncology

Treatment outcomes of radiotherapy for anaplastic thyroid cancer

Jong Won Park et al.

RADIATION ONCOLOGY JOURNAL (2018)

Article Endocrinology & Metabolism

Association of Baseline Neutrophil-to-Lymphocyte Ratio with Clinicopathological Characteristics of Papillary Thyroid Carcinoma

Dimitrios K. Manatakis et al.

INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (2017)

Review Endocrinology & Metabolism

Leveraging the immune system to treat advanced thyroid cancers

Jena D. French et al.

LANCET DIABETES & ENDOCRINOLOGY (2017)

Article Oncology

Prognostic impact of leukocyte counts before and during radiotherapy for oropharyngeal cancer

Garrett L. Jensen et al.

CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY (2017)

Review Cell Biology

Thyroid cancer and inflammation

Valentina Guarino et al.

MOLECULAR AND CELLULAR ENDOCRINOLOGY (2010)

Article Oncology

Multimodality treatment for anaplastic thyroid carcinoma - Treatment outcome in 75 patients

Annemarie T. Swaak-Kragten et al.

RADIOTHERAPY AND ONCOLOGY (2009)